Similarly, increasing evidence is implicating the CXC chemokines/cognate receptors signaling axes in the pathophysiology of ALS, suggesting that monitoring CXC-ligands (e.g. CXCR4) in ALS is important for tracking disease progression (La Cognata et al., 2024). The gene discussed is CXCR4; the disease is amyotrophic lateral sclerosis.